Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP269991.RAGLfq4LAIGr_1RWrADHJQ1t865XiJKpO7Gq2Wwnp9qM4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP269991.RAGLfq4LAIGr_1RWrADHJQ1t865XiJKpO7Gq2Wwnp9qM4130_assertion type Assertion NP269991.RAGLfq4LAIGr_1RWrADHJQ1t865XiJKpO7Gq2Wwnp9qM4130_head.
- NP269991.RAGLfq4LAIGr_1RWrADHJQ1t865XiJKpO7Gq2Wwnp9qM4130_assertion description "[Finally, decreased cell viability of Met receptor expressing breast cancer cells treated with delphinidin argues for a potential role of the agent in the prevention of HGF-mediated activation of various signaling pathways implicated in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP269991.RAGLfq4LAIGr_1RWrADHJQ1t865XiJKpO7Gq2Wwnp9qM4130_provenance.
- NP269991.RAGLfq4LAIGr_1RWrADHJQ1t865XiJKpO7Gq2Wwnp9qM4130_assertion evidence source_evidence_literature NP269991.RAGLfq4LAIGr_1RWrADHJQ1t865XiJKpO7Gq2Wwnp9qM4130_provenance.
- NP269991.RAGLfq4LAIGr_1RWrADHJQ1t865XiJKpO7Gq2Wwnp9qM4130_assertion SIO_000772 18499206 NP269991.RAGLfq4LAIGr_1RWrADHJQ1t865XiJKpO7Gq2Wwnp9qM4130_provenance.
- NP269991.RAGLfq4LAIGr_1RWrADHJQ1t865XiJKpO7Gq2Wwnp9qM4130_assertion wasDerivedFrom befree-20140225 NP269991.RAGLfq4LAIGr_1RWrADHJQ1t865XiJKpO7Gq2Wwnp9qM4130_provenance.
- NP269991.RAGLfq4LAIGr_1RWrADHJQ1t865XiJKpO7Gq2Wwnp9qM4130_assertion wasGeneratedBy ECO_0000203 NP269991.RAGLfq4LAIGr_1RWrADHJQ1t865XiJKpO7Gq2Wwnp9qM4130_provenance.